Detalhe da pesquisa
1.
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
Mol Pharmacol
; 95(2): 155-168, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30504240